Evaluation of Prepubertal Patients with Suspected Neurosecretory Dysfunction of Growth Hormone Secretion: Diagnostic Steps and Treatment Response

Figure 3

Change of IGF-I and IGFBP3 (in SDS) before diagnosis and 3 months after start of treatment/observation ( value < 0,005 in the NSD- and 0,194 in the non-NSD group).